Nkarta, Inc. (NKTX)
Data as of , from SEC Form 4 filings.
See up to 3 months of NKTX. The 7-day demo opens the 1M and 3M ranges and puts NKTX on your watchlist.
Start 7-day demoLatest NKTX insider trades
Paul J. Hastings - OfficerOpen-market sale$5K- Paul J. Hastings - OfficerOpen-market sale$54K
About Nkarta, Inc. (NKTX)
The SEC lists Nkarta, Inc. under CIK 0001787400, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
NKTX Form 4 activity by transaction type, last 90 days
No Form 4 activity for NKTX in the last 90 days.
NKTX insider transactions (Form 4)
1815 Form 4 filings on record, the earliest from Jun 5, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Paul J. Hastings - Officer | Open-market sale | Common Stock | 1,776 footnote F1 | $2.71 | $5K | |
| ||||||
| RA CAPITAL MANAGEMENT, L.P. | Grant or award | Stock Option (right to buy) | 37,000 | $0.00 | - | |
 Ali Behbahani | Grant or award | Stock Option (right to buy) | 37,000 | $0.00 | - | |
| Simeon George | Grant or award | Stock Option (right to buy) | 37,000 | $0.00 | - | |
| George Vratsanos | Grant or award | Stock Option (right to buy) | 37,000 | $0.00 | - | |
| Zachary Scheiner | Grant or award | Stock Option (right to buy) | 37,000 | $0.00 | - | |
| Leone D. Patterson | Grant or award | Stock Option (right to buy) | 37,000 | $0.00 | - | |
| Michael Dybbs | Grant or award | Stock Option (right to buy) | 37,000 | $0.00 | - | |
 Angela Thedinga | Grant or award | Stock Option (right to buy) | 37,000 | $0.00 | - | |
| Paul J. Hastings - Officer | Open-market sale | Common Stock | 26,046 footnote F1 | $2.07 | $54K | |
| ||||||
| Nadir Mahmood - Officer | Open-market sale | Common Stock | 5,649 footnote F1 | $2.07 | $12K | |
| ||||||
| Shawn Marshall Rose - Officer | Grant or award | Common Stock | 70,000 footnote F1 | $0.00 | - | |
| Shawn Marshall Rose - Officer | Grant or award | Stock Option (right to buy) | 139,000 | $0.00 | - | |
| ||||||
| Nadir Mahmood - Officer | Grant or award | Common Stock | 80,000 footnote F1 | $0.00 | - | |
| Nadir Mahmood - Officer | Grant or award | Stock Option (right to buy) | 160,000 | $0.00 | - | |
| ||||||
| Paul J. Hastings - Officer | Grant or award | Common Stock | 94,000 footnote F1 | $0.00 | - | |
| Paul J. Hastings - Officer | Grant or award | Stock Option (right to buy) | 562,000 | $0.00 | - | |
| ||||||
| Leone D. Patterson | Grant or award | Stock Option (right to buy) | 46,000 | $0.00 | - | |
NKTX insider trading FAQ
What is the latest insider trade for NKTX?
Nkarta, Inc. (NKTX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-22. The full record for NKTX runs to 15 Form 4 filings, the earliest from 2025-06-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NKTX stock?
No insider purchases of NKTX were filed in the last 90 days.
How many insiders are selling NKTX stock?
No insider sales of NKTX were filed in the last 90 days. 3 sales are on record for this company.
Where can I see NKTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NKTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Paul J. Hastings view on EDGAR
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - Ali Behbahani view on EDGAR
- - Simeon George view on EDGAR
- - George Vratsanos view on EDGAR
- - Zachary Scheiner view on EDGAR
- - Leone D. Patterson view on EDGAR
- - Michael Dybbs view on EDGAR
- - Angela Thedinga view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where NKTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NKTX with a 7-day demo
- NKTX on your watchlist
- Every NKTX Form 4 filing on record
- Up to 3 months of NKTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
